Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study

作者: Haijun Sun , Xianzhi Meng , Jihua Han , Zhe Zhang , Bing Wang

DOI: 10.1007/S13277-013-0963-0

关键词:

摘要: Treatment of gastric cancer remains a major challenge, and new anticancer drugs are urgently required. This study investigated whether dihydroartemisinin (DHA), semi-synthetic derivative artemisinin, could inhibit the growth both in vitro vivo. A series experiments including MTT, colony-forming, wound healing, invasion, cell cycle, cellular senescence, apoptosis assays were performed to examine antiproliferative antimetastatic effects DHA on three lines, SGC-7901, BGC823, MGC803. The result showed that proliferation rate colony-forming abilities cells significantly suppressed by together with significant suppression expressions markers (PCNA, cyclin E, D1), upregulation p21 p27. Moreover, induced G1 phase cycle arrest hindered migration invasion corresponding downregulation MMP-9 MMP-2. Furthermore, through suppressing Bcl-2 as well activating caspase-9 PARP. increased miR-15b miR-16 expression, caused Bcl-2, resulting cells. In vivo, our data inhibited SGC7901 cell-transplanted tumors. summary, we have shown is able metastasis human cancer. modulation mediated Our work suggested has against vivo vitro, indicating it promising therapy for

参考文章(30)
S. J. Kim, M. S. Kim, J. W. Lee, C. H. Lee, H. Yoo, S. H. Shin, M. J. Park, S. H. Lee, Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro Journal of Cancer Research and Clinical Oncology. ,vol. 132, pp. 129- 135 ,(2006) , 10.1007/S00432-005-0052-X
Devdutt Chaturvedi, Abhishek Goswami, Partha Pratim Saikia, Nabin C. Barua, Paruchuri G. Rao, Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents Chemical Society Reviews. ,vol. 39, pp. 435- 454 ,(2010) , 10.1039/B816679J
Yixing Jiang, Jaffer A Ajani, Multidisciplinary management of gastric cancer. Current Opinion in Gastroenterology. ,vol. 26, pp. 640- 646 ,(2010) , 10.1097/MOG.0B013E32833EFD9B
Ikuhiko Nakase, Henry Lai, Narendra P. Singh, Tomikazu Sasaki, Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. International Journal of Pharmaceutics. ,vol. 354, pp. 28- 33 ,(2008) , 10.1016/J.IJPHARM.2007.09.003
Lin Xia, Dexin Zhang, Rui Du, Yanglin Pan, Lina Zhao, Shiren Sun, Liu Hong, Jie Liu, Daiming Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer. ,vol. 123, pp. 372- 379 ,(2008) , 10.1002/IJC.23501
Jun Lee, Hui-Jun Zhou, Xiu-Hua Wu, None, Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemotherapy and Pharmacology. ,vol. 57, pp. 213- 220 ,(2006) , 10.1007/S00280-005-0002-Y
Jin-Jian Lu, Ling-Hua Meng, Yu-Jun Cai, Qin Chen, Lin-Jiang Tong, Li-Ping Lin, Jian Ding, Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. Cancer Biology & Therapy. ,vol. 7, pp. 1017- 1023 ,(2008) , 10.4161/CBT.7.7.6035
Deguang Mu, Wei Zhang, Dongling Chu, Tonggang Liu, Yonghong Xie, Enqing Fu, Faguang Jin, The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells Cancer Chemotherapy and Pharmacology. ,vol. 61, pp. 639- 645 ,(2008) , 10.1007/S00280-007-0517-5
Yang JIAO, Chun-min GE, Qing-hui MENG, Jian-ping CAO, Jian TONG, Sai-jun FAN, Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacologica Sinica. ,vol. 28, pp. 1045- 1056 ,(2007) , 10.1111/J.1745-7254.2007.00612.X